ArticleBrain : a journal of neurology2018

A novel metabolism-based phenotypic drug discovery platform in zebrafish uncovers HDACs 1 and 3 as a potential combined anti-seizure drug target.

Kingsley Ibhazehiebo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.